Deepak Gaur

[3] He did his doctoral studies at the National Institute of Immunology and after securing a PhD in 2001, he joined Jawaharlal Nehru University a post-doctoral work as a visiting fellow.

In 2006, he moved to the US on a Full-time equivalent position offered by the US Government and continued there till 2009 when he received the Ramalingaswami Fellowship of the Department of Biotechnology.

[4] This enabled him to return to India that year to join the Malaria Group of the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi.

[11] His research association with Suman Kumar Dhar, an N-Bios and Shanti Swarup Bhatnagar laureate, was successful in identifying acriflavine, an anti-parasitic drug in use in the 20th century, to be effective against Plasmodium falciparum and they have received a patent for their discovery.

He sat in the preliminary interview committee for Rhodes Scholarship in 2014 and was involved in the selection of final round candidates.